Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Aug 08, 2022 6:45pm
222 Views
Post# 34880181

RE:RE:RE:FDA Accelerated Approval example

RE:RE:RE:FDA Accelerated Approval exampleImmunityBio has submitted its BLA.  It can take the FDA up to 2y (mostly 1y) to approve it as it involves going through the verification of their manufacturing facilities and processes.

TLT will rather go the NDA route, which is less complex.

How long does it take for BLA approval?
 
At the end of your Phase III trial, you can submit your BLA to the FDA, but it can still take up to two years to gain approval.
 
 

 

Would TLD1433 be considered a BLA or a NDA?   I found this in an interview:
 
If Theralase is able to complete the preclinical studies using TLD 1433, the company will be in a position to have a pre-New Drug Application(pre-NDA) meeting sometime during Q4 20xx and, potentially, be on track to file the NDA after.

 


So BLA requires a longer approval process than a NDA.  If accurate, by the time ImmunityBio obtains its BLA approval, we will have accumulated enough statistically significant data to know if we could beat them.

<< Previous
Bullboard Posts
Next >>